HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prostaglandin E2 induction of labor for isolated oligohydramnios in women with unfavorable cervix at term.

AbstractOBJECTIVE:
To evaluate the maternal and neonatal outcomes of pregnancies complicated with isolated oligohydramnios at term, managed by induction of labor.
METHODS:
We conducted a retrospective case-control study. 138 women with uncomplicated oligohydramnios at term [amniotic fluid index (AFI) < or =5 cm] and a low Bishop score (< or =6) underwent induction of labor with prostaglandin E2. These women were compared to 67 women who underwent induction of labor at 42 weeks' gestation and 276 women at low-risk pregnancy and spontaneous onset of labor, matched for parity and race.
RESULTS:
Cesarean section (CS) rate was similar in the study and the post-date group (17.4 and 17.9%, respectively), but significantly higher than the spontaneous labor group (5.8%, OR 3.42, 95% CI 1.75-6.68). No differences were found with other outcomes.
CONCLUSION:
Pregnancies with isolated oligohydramnios at term apparently are not at higher risk of perinatal complications, but induction of labor is associated with increased rate of CS.
AuthorsD Danon, A Ben-Haroush, Y Yogev, J Bar, M Hod, J Pardo
JournalFetal diagnosis and therapy (Fetal Diagn Ther) Vol. 22 Issue 1 Pg. 75-9 ( 2007) ISSN: 1015-3837 [Print] Switzerland
PMID17003561 (Publication Type: Journal Article)
Chemical References
  • Oxytocics
  • Dinoprostone
Topics
  • Case-Control Studies
  • Cesarean Section
  • Delivery, Obstetric (statistics & numerical data)
  • Dinoprostone (adverse effects)
  • Female
  • Humans
  • Labor, Induced (adverse effects, methods)
  • Oligohydramnios
  • Oxytocics (adverse effects)
  • Pregnancy
  • Pregnancy Outcome
  • Retrospective Studies
  • Term Birth

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: